REQUEST A DEMO
Total
USD $0.00
Search more companies

Jayanth Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Jayanth Pharmaceuticals Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Jayanth Pharmaceuticals Private Limited is an unlisted company, incorporated on 31/01/2002. It has its registered office in the State of Telangana, India. Company's corporate identification number (CIN) is U24239TG2002PTC038432 and registration number is 038432. The company is a manufacturing company, it is engaged in manufacture of chemicals and chemical products.

Legal Address
Pl.No 4A,Phase 1,Ida, Cherlapally
Rangareddy; Andhra Pradesh; Postal Code: 500051

Contact Details: Purchase the Jayanth Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Jayanth Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Jayanth Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Jayanth Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
January 31, 2002
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Jayanth Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-1.6%
Total operating revenue
-1.65%
Operating profit (EBIT)
5.5%
EBITDA
22.3%
Net Profit (Loss) for the Period
21.84%
Total Assets
-4.31%
Total Equity
69.67%
Operating Profit Margin (ROS)
0.73%
Net Profit Margin
0.81%
Return on Equity (ROE)
-4.05%
Debt/Equity
-149.97%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?